Connect with us

Government

Hot Stocks To Buy Right Now? 3 Health Care Stocks For Your Watchlist

Are these on your list of best health care stocks to buy right now? 
The post Hot Stocks To Buy Right Now? 3 Health Care Stocks For Your Watchlist appeared…

Published

on

3 Top Health Care Stocks To Watch Right Now

As the stock market continues to show volatility, some investors may flock to more defensive stocks such as health care stocks. Admittedly, the current global pandemic does influence the sentiment around the health care sector. However, this is an industry that will always have demand no matter the circumstances. Take Alnylam Pharmaceuticals’ (NASDAQ: ALNY) recent financial report for example. The company reported a revenue of $662 million for the fiscal year 2021, an increase of 83% compared to the prior year. Now, Alnylam expects its product sales for the full year of 2022 to be up to $1 billion. So, despite still loss-making for the quarter, it does give us a picture that the demand for its products and services is still rising.  

Furthermore, the demand for COVID-19 related products is also not slowing down. With speculations of the need for more booster doses due to new variants, vaccine companies such as Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) will likely continue to benefit from the current predicament. We also saw Eli Lilly and Company (NYSE: LLY) announcing an agreement with the U.S. government to supply up to 600,000 doses of its investigation drug bebtelovimab. It appears that the government will accept the doses if it is granted an Emergency Use Authorization by the U.S. Food and Drug Administration. With all said and done, it is no surprise that many believe health care stocks could continue to grow. So, here are some of the top names in the stock market today.  

Health Care Stocks To Watch This Month

Vir Biotechnology 

Vir is a clinical-stage immunology company that focuses on the management of serious infectious diseases. As of now, it has four technology platforms focusing on antibodies, T-cells, innate immunity, and small interfering ribonucleic acid. Its development pipeline consists of product candidates targeting the COVID-19, hepatitis B virus (HBV), human immunodeficiency virus (HIV), and influenza A virus. It is no secret that VIR stock has been struggling over the past year. However, there are also reasons to believe that better days could be ahead for the company.  

For starters, Vir announced in January an expansion of its partnership with the Bill & Melinda Gates Foundation. The continuous collaboration is to include the advancement of innovative platform technologies in the development of broadly neutralizing antibodies to provide a “vaccinal effect” for the treatment of HIV and the prevention of malaria. This vaccinal antibody concept is also currently being applied across its pipeline of potential product candidates. In addition, the company will utilize it to address other infectious diseases with high impact in low- and medium-income countries.  

On top of that, the company recently announced preclinical data that suggests its sotrovimab could retain neutralizing activity against the BA.2 subvariant of Omicron. For those unaware, this is an investigational monoclonal antibody developed in conjunction with GlaxoSmithKline (NYSE: GSK). It appears that a 500mg dose of the drug would retain activity against the variant, just as it has against all other variants of concern. Given these latest developments, do you believe VIR stock could make a turnaround soon?  

VIR stock
Source: TD Ameritrade TOS

[Read More] Stock Market Today: Dow Jones, S&P 500 Opens Higher; Zillow Gains On Earnings Beat

Ensign 

Another top health care company to note right now would be Ensign. Essentially, it engages in providing a range of skilled nursing and senior living services, physical, occupational, and other rehabilitative and health care services. Having approximately 248 health care facilities around the country, Ensign is one of the leading companies in what it does. Despite trading sideways for the majority of the past year, it has picked up some momentum recently, rising more than 7% over the past week.  

Ensign started the month by announcing the acquisition of two skilled nursing facilities in California. Firstly, there is the 119-bed skilled nursing facility located in San Bernardino, the Arrowhead Springs Healthcare. The other one would be the Desert Mountain Care Center, a 99-bed skilled nursing facility located in Indio. These additions to the company’s California operations will strengthen its local clusters. Not to mention, it will further enhance its ability to provide top-notch care to the patients it serves.  

Investors should also note that Ensign announced its fourth-quarter earnings report earlier this week. To say the least, it was an impressive quarter that met analysts’ expectations. The company’s GAAP diluted earnings per share for the quarter was $0.86, representing an increase of 4.9% year-over-year. Meanwhile, its adjusted earnings per share was a record $0.97, up by 21.3% year-over-year. Besides that, the company also provided an optimistic annual 2022 earnings guidance of $4.01 to $4.13 per diluted share. With that said, would you consider investing in ENSG stock? 

ENSG stock chart
Source: TD Ameritrade TOS

Read More

Envista 

Unlike the previous two entries, Envista is a dental products company. In detail, its products focus on the diagnosis, treatment, and prevention of disease and ailments of teeth and the periodontium. It operates through two segments, Specialty Products & Technologies, and Equipment & Consumables. On one hand, its Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, dental prosthetics, and others. Meanwhile, the Equipment & Consumable segment specializes in dental equipment and supplies used in dental offices. This includes digital imaging systems, magnification systems, and other essentials in a dental office.  

Yesterday, Envista announced its fourth-quarter and full-year 2021 financial results. For the quarter, the company’s core sales grew by 6.6% year-over-year. Besides that, its adjusted net income was $81.1 million, representing an increase of 12% compared to the prior year’s quarter. Now, the company believes that it could deliver core growth of between 6-8% and deliver a full-year adjusted EBITDA margin of over 30% next year. Overall, Envista grew significantly above pre-pandemic levels and continues to show promise long-term. 

Not to mention, it also recently announced that it has renewed its partnership agreement with Vitaldent Group. The Spanish Dental Service Organization provides quality, accessible odontology to patients using the most advanced technology and professional care. The agreement reaffirms the commitment of Vitaldent’s network of clinics to provide the highest quality products and services in all treatments. Ultimately, it would make Envista the preferred supplier of implants and clear aligners in many markets around the world. All things considered, would you consider NVST stock a top health care stock to watch?

NVST stock
Source: TD Ameritrade TOS

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!


The post Hot Stocks To Buy Right Now? 3 Health Care Stocks For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Government

Walmart joins Costco in sharing key pricing news

The massive retailers have both shared information that some retailers keep very close to the vest.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Government

Walmart has really good news for shoppers (and Joe Biden)

The giant retailer joins Costco in making a statement that has political overtones, even if that’s not the intent.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Trending